Yesterday, CBS Sunday Morning featured a story on the anaplastic lymphoma kinase, or ALK, clinical trial for lymphoma and neuroblastoma and CHOP’s partnership with the Alex's Lemonade Stand Foundation, which supported the basic research.
About a year ago, Children’s Hospital investigator and oncologist Yaël P. Mossé, MD, made headlines around the world with news that a drug originally developed for use in adults with lung cancer showed amazing results in early trials in children with two aggressive forms of cancer — anaplastic large-cell lymphoma and neuroblastoma.
Reporter Tracy Smith was the first nationally to interview Alex Scott. Sunday's story showed how the Foundation has grown, the role of CHOP’s Cancer Center in caring for Alex, and the subsequent collaboration to advance pediatric cancer research.
To see the entire video, please click here.